Literature DB >> 12204970

Performance of two commercial glycoprotein G-based enzyme immunoassays for detecting antibodies to herpes simplex viruses 1 and 2 in children and young adolescents.

Charles T Leach1, Rhoda L Ashley, Jacques Baillargeon, Hal B Jenson.   

Abstract

In 61 patients 1 to 14 years of age, the Gull/Meridian enzyme-linked immunosorbent assay (ELISA) had a sensitivity of 100% for herpes simplex virus type 1 (HSV-1) and specificities of 74% for HSV-1 and 48% for HSV-2. In 128 similarly aged patients, the HerpeSelect ELISA (Focus Technologies) showed sensitivities of 80% for HSV-1 and 88% for HSV-2, and specificities of 97% for HSV-1 and 100% for HSV-2.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12204970      PMCID： PMC120053          DOI： 10.1128/cdli.9.5.1124-1125.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


  13 in total

Review 1.  Sorting out the new HSV type specific antibody tests.

Authors:  R L Ashley
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

2.  Herpes simplex virus type 2 in the United States, 1976 to 1994.

Authors:  D T Fleming; G M McQuillan; R E Johnson; A J Nahmias; S O Aral; F K Lee; M E St Louis
Journal:  N Engl J Med       Date:  1997-10-16       Impact factor: 91.245

3.  Is sexual transmission an important pattern for herpes simplex type 2 virus seroconversion in the Spanish general population?

Authors:  P García-Corbeira; R Dal-Ré; L Aguilar; J J Granizo; J García-de-Lomas
Journal:  J Med Virol       Date:  1999-10       Impact factor: 2.327

4.  Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies.

Authors:  R L Ashley; L Wu; J W Pickering; M C Tu; L Schnorenberg
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

5.  Use of a glycoprotein G-based type-specific assay to detect antibodies to herpes simplex virus type 2 among persons attending sexually transmitted disease clinics.

Authors:  W L Whittington; C L Celum; A Cent; R L Ashley
Journal:  Sex Transm Dis       Date:  2001-02       Impact factor: 2.830

6.  A novel glycoprotein for detection of herpes simplex virus type 1-specific antibodies.

Authors:  F K Lee; L Pereira; C Griffin; E Reid; A Nahmias
Journal:  J Virol Methods       Date:  1986-09       Impact factor: 2.014

7.  Detection of herpes simplex virus type 2-specific antibody with glycoprotein G.

Authors:  F K Lee; R M Coleman; L Pereira; P D Bailey; M Tatsuno; A J Nahmias
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

8.  Inability of enzyme immunoassays to discriminate between infections with herpes simplex virus types 1 and 2.

Authors:  R Ashley; A Cent; V Maggs; A Nahmias; L Corey
Journal:  Ann Intern Med       Date:  1991-10-01       Impact factor: 25.391

9.  Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera.

Authors:  R L Ashley; J Militoni; F Lee; A Nahmias; L Corey
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

Review 10.  Natural history, management and complications of herpes labialis.

Authors:  C R Higgins; J K Schofield; F M Tatnall; I M Leigh
Journal:  J Med Virol       Date:  1993       Impact factor: 2.327
View more
  9 in total

1.  Performance and use of a ribonucleotide reductase herpes simplex virus type-specific serological assay.

Authors:  S Q Wales; C C Smith; M Wachsman; G Calton; L Aurelian
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

2.  Evaluation of the HerpeSelect Express rapid test in the detection of herpes simplex virus type 2 antibodies in patients with genital ulcer disease.

Authors:  Hani Al-Shobaili; Khaled M Hassanein; Marwa Salah Mostafa; Ali Saleh Al Duways
Journal:  J Clin Lab Anal       Date:  2014-03-28       Impact factor: 2.352

3.  Performance of the HerpeSelect (Focus) and Kalon enzyme-linked immunosorbent assays for detection of antibodies against herpes simplex virus type 2 by use of monoclonal antibody-blocking enzyme immunoassay and clinicovirological reference standards in Brazil.

Authors:  Maria Claudia Nascimento; Suzete Ferreira; Ester Sabino; Ingrid Hamilton; John Parry; Claudio S Pannuti; Philippe Mayaud
Journal:  J Clin Microbiol       Date:  2007-05-16       Impact factor: 5.948

Review 4.  Medical and legal implications of testing for sexually transmitted infections in children.

Authors:  Margaret R Hammerschlag; Christina D Guillén
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

5.  Acute retinal necrosis caused by herpes simplex virus type 2 in a 3-year-old Japanese boy.

Authors:  Naoko Tanaka-Kitajima; Naomi Iwata; Yoshihiro Ando; Hiroko Sakurai; Mio Iwami; Kin-ichi Tsuzuki; Mineo Kondo; Yoshinori Ito; Hiroshi Kimura
Journal:  Eur J Pediatr       Date:  2008-12-03       Impact factor: 3.183

Review 6.  Clinical and therapeutic issues for herpes simplex virus-2 and HIV co-infection.

Authors:  Jairam R Lingappa; Connie Celum
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 7.  Neonatal herpes simplex infection.

Authors:  David W Kimberlin
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

8.  Serological diagnosis of human herpes simplex virus type 1 and 2 infections by luciferase immunoprecipitation system assay.

Authors:  Peter D Burbelo; Yo Hoshino; Hannah Leahy; Tammy Krogmann; Ronald L Hornung; Michael J Iadarola; Jeffrey I Cohen
Journal:  Clin Vaccine Immunol       Date:  2009-01-07

9.  Seroprevalence of HSV-1 and HSV-2 in Barbados.

Authors:  P N Levett
Journal:  Med Microbiol Immunol       Date:  2005-01       Impact factor: 3.402
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.